BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Angiogenesis
,
Obesity
,
Lung
,
Holistic medicine
,
Bleomycin
,
rs7903146
,
MDM2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
complement 5a
Summary
General Info
Curated Studies
Most Correlated Studies
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation…
Complement C5a Implication in Axonal Growth After Injury.
Serum Depletion of Complement Component 5a Is Associated With Increased Inflammation and Poor Clinic…
NETosis Is Induced by Complement Component 5a: Implications in the Pathogenesis of Pyoderma Gangreno…
C5a complement levels in clinical remission AQP4-IgG-positive NMO patients.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Novel Inflammatory Biomarkers Complement 5A and Hepcidin in Patients With Gaucher Disease (GD)
Complement Inhibition in aHUS Dialysis Patients
Organization of Smoking Cessation in Pregnant Women With the Implementation of the 5A Strategy in Ne…
Complement C5a Receptors in Hidradenitis Suppurativa
A Study of Commercial DEFINITY® to Monitor the Effects of the Heart's Pulmonary Artery Pressure
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ